Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Equity (2018 - 2025)

Arcus Biosciences has reported Return on Equity over the past 8 years, most recently at 0.66% for Q4 2025.

  • Quarterly results put Return on Equity at 0.66% for Q4 2025, down 12.0% from a year ago — trailing twelve months through Dec 2025 was 0.66% (down 12.0% YoY), and the annual figure for FY2025 was 0.63%, down 3.0%.
  • Return on Equity for Q4 2025 was 0.66% at Arcus Biosciences, up from 0.69% in the prior quarter.
  • Over the last five years, Return on Equity for RCUS hit a ceiling of 0.11% in Q3 2022 and a floor of 0.77% in Q1 2025.
  • Median Return on Equity over the past 5 years was 0.45% (2024), compared with a mean of 0.38%.
  • Biggest five-year swings in Return on Equity: surged 60bps in 2022 and later tumbled -65bps in 2023.
  • Arcus Biosciences' Return on Equity stood at 0.08% in 2021, then crashed by -614bps to 0.39% in 2022, then tumbled by -59bps to 0.63% in 2023, then grew by 14bps to 0.54% in 2024, then fell by -23bps to 0.66% in 2025.
  • The last three reported values for Return on Equity were 0.66% (Q4 2025), 0.69% (Q3 2025), and 0.55% (Q2 2025) per Business Quant data.